Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens

2004 ◽  
Vol 348 (1-2) ◽  
pp. 19-25 ◽  
Author(s):  
Amitava Dasgupta ◽  
Omar Chughtai ◽  
Christina Hannah ◽  
Bonnette Davis ◽  
Alice Wells
2020 ◽  
Vol 2020 ◽  
pp. 1-14
Author(s):  
Rui Yang ◽  
Yonglin Zhang ◽  
Zhenrong Deng ◽  
Wenming Huang ◽  
Rushi Lan ◽  
...  

To accurately detect small defects in urine test strips, the SK-FMYOLOV3 defect detection algorithm is proposed. First, the prediction box clustering algorithm of YOLOV3 is improved. The fuzzy C-means clustering algorithm is used to generate the initial clustering centers, and then, the clustering center is passed to the K-means algorithm to cluster the prediction boxes. To better detect smaller defects, the YOLOV3 feature map fusion is increased from the original three-scale prediction to a four-scale prediction. At the same time, 23 convolutional layers of size 3 × 3 in the YOLOV3 network are replaced with SkNet structures, so that different feature maps can independently select different convolution kernels for training, improving the accuracy of defect classification. We collected and enhanced urine test strip images in industrial production and labeled the small defects in the images. A total of 11634 image sets were used for training and testing. The experimental results show that the algorithm can obtain an anchor frame with an average cross ratio of 86.57, while the accuracy rate and recall rate of nonconforming products are 96.8 and 94.5, respectively. The algorithm can also accurately identify the category of defects in nonconforming products.


2016 ◽  
Vol 181 (3) ◽  
pp. 199-201 ◽  
Author(s):  
Shannon F. Reeve ◽  
Jamie S. Johnson ◽  
Robin Marshall

Thyroid ◽  
2009 ◽  
Vol 19 (8) ◽  
pp. 919-919 ◽  
Author(s):  
Elizabeth N. Pearce ◽  
John H. Lazarus ◽  
Peter P. Smyth ◽  
Xuemei He ◽  
Derek F. Smith ◽  
...  

2019 ◽  
Vol 493 ◽  
pp. S612-S613
Author(s):  
J. Boutin ◽  
B. Colombies ◽  
A. Berard ◽  
S. Dabernat ◽  
B. Rucheton

1999 ◽  
Vol 45 (8) ◽  
pp. 1315-1317 ◽  
Author(s):  
Jos T Van Acker ◽  
Alain G Verstraete ◽  
Marina A Van Hamme ◽  
Joris R Delanghe
Keyword(s):  

2020 ◽  
Vol 24 (5) ◽  
pp. 489-490
Author(s):  
Joris R. Delanghe ◽  
Marc L. De Buyzere ◽  
Matthijs Oyaert ◽  
Sigurd E. Delanghe ◽  
Marijn M. Speeckaert

1992 ◽  
Vol 6 (2) ◽  
pp. 145-148 ◽  
Author(s):  
Christoph Kaiser ◽  
Felix Bergel ◽  
Ekkehard Doehring-Schwerdtfeger ◽  
Hermann Feldmeier ◽  
Jochen H. H. Ehrich

2005 ◽  
Vol 20 (2) ◽  
pp. 134-136 ◽  
Author(s):  
M. Zancan ◽  
R. Franceschini ◽  
C. Mimmo ◽  
M. Vianello ◽  
F. Di Tonno ◽  
...  

The aim of the present preliminary study was to investigate the presence of free DNA (FDNA) in urine as a possible marker for the diagnosis of bladder cancer. Naturally voided morning urine specimens were collected from 57 patients with suspected bladder cancer before cystoscopy. A standard urine test was performed; the specimens were then processed in order to obtain a quantitative evaluation of the presence of free DNA in the urine. Twenty-two patients were excluded from the study because they had leukocyturia and/or bacteriuria. Free DNA concentrations higher than 250 ng/mL were found in all 16 patients showing bladder cancer at cystoscopy and in seven (36.8%) of the 19 patients with negative cystoscopy. Urinary FDNA seems to have an excellent sensitivity: we observed no false negative cases and 36.8% false positive cases. By contrast, only 6.25% of the bladder cancer patients had positive urine cytology. Our results seem promising, although further studies and larger numbers are needed to define urinary free DNA as a reliable marker of bladder cancer.


Sign in / Sign up

Export Citation Format

Share Document